Mesoblast Limited vs Roblox Corp — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while Roblox Corp trades at $52.5 (market cap $38.13B). The key difference: Roblox Corp is far larger — about 17.6× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals.
| MESO | RBLX | |
|---|---|---|
Market Cap | $2.17B | $38.13B |
Sector | Technology | Media |
52-Week High | $20.96 | $141.56 |
52-Week Low | $12.88 | $41.30 |
Enterprise Value | $2.17B | $36.71B |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →